Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Samsung Biologics Chooses STARLIMS

Published: Saturday, June 02, 2012
Last Updated: Saturday, June 02, 2012
Bookmark and Share
STARLIMS will provide Samsung its LIMS software to help enhance functional support for quality assurance laboratory testing and for storing and delivering analytical test results.

Samsung is known for electronics not biotechnology, but that could change in future years as Samsung Biologics has opened a new state of the art biologics development and production facility in Incheon, Korea.  To assure ongoing compliance with biologics manufacturing quality standards, Samsung BioLogics chose STARLIMS to be its LIMS provider. 

 “STARLIMS will provide Samsung its LIMS software to help enhance functional support for quality assurance laboratory testing and for storing and delivering analytical test results,” said Thomas Li, account manager, STARLIMS Asia Pacific.  “STARLIMS passed a thorough audit and evaluation by Samsung Biologics, which demonstrates our capability to support the business needs of a world class customer operating a large contract product development and manufacturing facility.”


The new Incheon facility will develop and manufacture a wide range of biologics products through genetic engineering technologies, cell culturing and purification.  By 2013, Samsung Biologics will offer a broad range of mammalian cell based, cGMP manufacturing services for cell line development, process and analytical development, clinical and commercial manufacturing, as well as aseptic fill and finish operations.

 

“Our biologics facility is capable of producing high quality bulk drug products.  We are pleased that our quality control department is relying on STARLIMS leading edge laboratory informatics solutions to help guarantee that all process and final production are high quality, meet global regulatory standards, and maximize customer satisfaction,” said Ming fang Hong, quality control team leader, Samsung Biologics. 



Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
Food and Drug Administration will begin implementing Abbott’s STARLIMS LIMS as part of the agency’s initiative to enhance FDA testing laboratories.
Monday, July 09, 2012
STARLIMS Acquires Distributor in Australia
Abbott has acquired STARLIMS’s Asia Pacific distribution partner.
Saturday, June 02, 2012
STARLIMS Expanding Global Market Presence in Forensics
STARLIMS is expanding its worldwide presence in the forensics market with products and applications designed for crime labs, evidence collection teams and police property rooms.
Saturday, June 02, 2012
STARLIMS to Provide LIMS to Australian Red Cross Blood Services
STARLIMS' LIMS software has been adopted by the Australian Red Cross Blood Services (ARCBS) to manage information and data in its blood products manufacturing and transplantation laboratories.
Saturday, June 02, 2012
Abbott’s STARLIMS Business Acquires Distribution Partners to Build International Presence
Acquisitions part of a series of strategic moves to build Abbott's LIMS business in Europe and emerging markets in Latin America and Africa
Saturday, May 12, 2012
STARLIMS Expands Global Customer Service and Support
Resources from Abbott help build new, global customer care organization
Wednesday, April 25, 2012
STARLIMS Acquires International Distribution Partners
STARLIMS Technologies, an Abbott company, has announced the acquisition of several longtime distribution partners
Sunday, March 11, 2012
StarLIMS wins FDA software deal
The company will supply its lab management solutions for FDA testing laboratories.
Wednesday, February 01, 2012
Abbott’s STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
STARLIMS and Abbott have announced that the FDA will begin implementing STARLIMS LIMS solution as part of the agency’s initiative to enhance FDA’s testing laboratories.
Tuesday, January 24, 2012
Dr Lal PathLabs Selects STARLIMS Software for LIMS
STARLIMS will be implemented for use in its entire network consisting of the National Reference Lab (NRL) in New Delhi
Tuesday, November 29, 2011
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
A Peachy Defense System for Seeds
ETH chemists are developing a new coating method to protect seeds from being eaten by insects. In doing so, they have drawn inspiration from the humble peach and a few of its peers.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!